Tag: Philips

Q&A with Philips Digital Pathology

| June 23, 2017 | 0 Comments

I recently had an opportunity to speak with Esther Abels, Director of Regulatory, Clinical and Medical Affairs for Philips Digital Pathology Solutions about Philips’ recent approval to market their Philips Intellisite Pathology System (PIPS) for primary diagnosis of biopsies and excisions in the United States. My thanks to Esther and Philips’ marketing team for their […]

Continue Reading

Tomorrow’s Webinar from Philips: Unlocking the Full Potential of Digital Pathology

| June 12, 2017 | 0 Comments

Tuesday, June 13th, Philips Digital Pathology Solutions will host two webinars for: North America: 10:00 AM – 11:00 AM EDT Register Asia & Europe: 3:00 PM – 4:00 PM SGT Register Philips IntelliSite Pathology Solution is now available for primary diagnostic use in the USA; but what does this news mean for the field of pathology? In […]

Continue Reading

Webinar: Unlocking the Full Potential of Digital Pathology

| May 31, 2017 | 0 Comments

Tuesday, June 13th, Philips Digital Pathology Solutions will host two webinars for: North America: 10:00 AM – 11:00 AM EDT Register Asia & Europe: 3:00 PM – 4:00 PM SGT Register Philips IntelliSite Pathology Solution is now available for primary diagnostic use in the USA; but what does this news mean for the field of […]

Continue Reading

What does FDA Approval Mean for the Digital Pathology Market? Part 1

| May 15, 2017 | 0 Comments

Much is being said, written and discussed about the recent FDA clearance for Philips digital pathology solution for primary H&E diagnosis. Of course, this means an advantage for Philips right now in the market as the only FDA approved whole slide imaging system for primary diagnosis. For groups and hospitals that appreciate the two main […]

Continue Reading

162 Days of Change

| April 17, 2017 | 1 Comment

As of last Thursday, April 12, 2017 and going back to a rainy night in Cleveland on November 2, 2016, the past 162 days have seen at least 3 things most Americans, and perhaps many across the world thought they would never see happen in their lifetimes. That rainy night in Cleveland started the clock […]

Continue Reading

FDA Allows Marketing of First Whole Slide Imaging System for Digital Pathology

| April 13, 2017 | 1 Comment

Welcome news anticipated from FDA for some time with recent Philips submission for approval. Philips Intellisite Pathology Solution (PIPS) first WSI system approved with special controls on the system to insure patient safety. More to follow on FDA approval of WSI for clinical use! The U.S. Food and Drug Administration today permitted marketing of the […]

Continue Reading

Philips and LabPON Plan to Create World’s Largest Pathology Database of Annotated Tissue Images for Deep Learning

| March 6, 2017 | 0 Comments

Best, the Netherlands – Royal Philips (NYSE: PHG, AEX: PHIA) and LabPON, the first clinical laboratory to  transition to 100% histopathology digital diagnosis, today announced its plans to create a digital database of massive aggregated sets of annotated pathology images and big data utilizing Philips IntelliSite Pathology Solution1. The database will provide pathologists with a […]

Continue Reading

Philips Introduces New Digital Solutions and Services to Advance Pathology at the 2017 USCAP Annual Meeting

| March 2, 2017 | 0 Comments

San Antonio TX, USA – Royal Philips (NYSE: PHG, AEX: PHIA) recently announced upcoming additions to its portfolio of pathology solutions as part of its presence at the 2017 USCAP Annual Meeting. At the Philips booth (#202), USCAP attendees will experience a broadened portfolio of computational pathology and digital pathology solutions and services that extend […]

Continue Reading

Join Dr. Bas Hulsken’s Webinar to Discover the Benefits of an Open Pathology Platform

| January 12, 2017 | 0 Comments

Tuesday, January 24th 2017 4.00 PM – 5.00 PM GMT Since the development of modern anatomical pathology as a medical discipline in the 19th Century it has been uniquely bound to the location of the specimen, requiring direct (microscopic) inspection of the biopsy. Today, digital pathology is breaking those bonds, allowing the practice of anatomical pathology […]

Continue Reading

Multi-Center Clinical Validation Study by Philips to be Submitted to FDA in Support of Expanded Indications for Use for Philips IntelliSite Digital Pathology Solution in the U.S.

| October 24, 2016 | 0 Comments

Great news from Philips who announced on October 21st their completion of a glass versus digital concordance study to be submitted to FDA.  The press release mentions 2,000 cases with approximately 16,000 reads. The press release goes on to say that the final discordance rate was 1%. Philips will submit the results of the study along […]

Continue Reading

Philips and Spanish Hospital Campus de la Salud Start Implementation of Multi-Year Strategic Partnership Agreement

| July 15, 2016 | 0 Comments

Multi-year strategic partnership includes managed equipment services agreement to install and manage diagnosis, therapy and connected care technologies at Campus de la Salud Hospital, which offers advanced care to over 900,000 people in Granada, Spain Includes Spain’s first fully digital pathology lab and Philips’ latest innovations in image-guided minimally invasive therapy and patient monitoring Amsterdam, the […]

Continue Reading

Inspirata Announces Digital Pathology Workflow Deployment at The Ohio State University

| July 5, 2016 | 0 Comments

Big news today from Inspirata and The Ohio State University Comprehensive Cancer Center (OSUCCC) – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute laying out their goals for a comprehensive digital pathology solution to support clinical workflow operations.   Dr. Anil Parwani, Professor of Pathology, Vice Chair and Director of Anatomical Pathology and Director […]

Continue Reading

Philips Teams Up With Visiopharm to Boost Breast Cancer Diagnosis Objectivity Through Computational Pathology

| June 22, 2016 | 0 Comments

More news from Philips this week – announcing a licensing agreement with Visiopharm to combine Visiopharm’s breast cancer panel with Philips’ Intellisite digital pathology solution. From a scientific standpoint, as the references mentioned point out, image analysis is critical to appropriate patient care, increasing consistency and reproducibility, if not accuracy, with increased efficiencies for pathologists […]

Continue Reading

Philips Acquires PathXL

| June 21, 2016 | 0 Comments

Interesting news that broke this morning in Europe from Royal Philips and PathXL. Press release courtesy of Philips. In an email from PathXL this morning, they mention “no immediate change to the way business is transacted. You can continue to count on operational support from the same customer team and contacts that you currently have. […]

Continue Reading